Fair Value Measurements - Narrative (Details) - License - USD ($) |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2022 |
Aug. 31, 2022 |
Oct. 31, 2021 |
Aug. 31, 2021 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Number of shares received | 397,562 | ||||
| Ji Xing Pharmaceuticals Limited | Significant Unobservable Inputs (Level 3) | Fair Value, Nonrecurring | Beneficial Owner | |||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Number of shares received | 397,561 | 397,562 | |||
| Impairment of investment | $ 0 | $ 0 |